How has Insulet's trading securities in marketable securities changed year-over-year?

Insulet's trading securities in marketable securities decreased by 0.0% year-over-year, from $19.1M to $19.1M.

What is the long-term trend for Insulet's trading securities in marketable securities?

Over 2 years (2023 to 2025), Insulet's trading securities in marketable securities has grown at a 40.3% compound annual growth rate (CAGR), from $9.7M to $19.1M.

Insulet PODD Trading Securities in Marketable Securities

Trading Securities in Marketable Securities at other companies

MedtronicMDT

——

Other financials

Income statement

See full

Revenue$761.7M+33.9%

Gross profit$529.0M+29.3%

Operating income$122.1M+37.5%

Net income$91.1M+157%

EPS (diluted)$1.30+160%

Balance sheet

See full

Cash & equivalents$480.4M-62.6%

Total debt$969.7M-45.5%

Total equity$1.3B-2.1%

Total assets$3.0B-15.1%

Cash flow

See full

Operating cash flow$113.8M+78.4%

CapEx$24.3M+97.6%

Free cash flow$89.5M+73.8%

Valuation

See full

Market cap$10.1B-19.9%

Enterprise value$10.59B-19.4%

P/E33.3×+2.0×

P/S3.5×-2.3×

Profitability

See full

Gross margin71%+0.6pp

Operating margin17.5%+2.0pp

Net margin10.4%-7.9pp

FCF margin14.3%+1.1pp

Returns & leverage

See full

Return on equity23%-14.9pp

Debt / equity0.7×-0.6×

Current ratio2.5×-2.0×

Where this comes from

Reported directly by Insulet in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount.

The official record: Insulet’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Insulet's trading securities in marketable securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Insulet's trading securities in marketable securities?: Insulet (PODD) reported trading securities in marketable securities of $19.1M in Q1 2026.
How has Insulet's trading securities in marketable securities changed year-over-year?: Insulet's trading securities in marketable securities decreased by 0.0% year-over-year, from $19.1M to $19.1M.
What is the long-term trend for Insulet's trading securities in marketable securities?: Over 2 years (2023 to 2025), Insulet's trading securities in marketable securities has grown at a 40.3% compound annual growth rate (CAGR), from $9.7M to $19.1M.